Intrinsiqs

Is Eloxx Pharmaceuticals, Inc. overvalued?

Eloxx Pharmaceuticals, Inc. (ELOX) — key valuation metrics and fundamentals.

No verdict
Price
$15.75
Fair value
Current P/E
Normal P/E
Market cap
$54.1M
Dividend yield
0.0%
Return on equity
-42.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ELOX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 9 Sep 2026.